CLOV vs KROS · rev $1.37B vs rev $3.5M
Clover Health Investments Corp (CLOV) versus Keros Therapeutics Inc (KROS) — a side-by-side from cached financials, not a winner call.
Clover Health Investments Corp (CLOV) is a healthcare plans company listed on US.
Keros Therapeutics Inc (KROS) is a biotechnology company listed on US.
Latest reported CLOV revenue for 2024-12-31 was $1.37B. Net income was -$43.0M. Revenue was up 8.8% from 2023-12-31 to 2024-12-31. CLOV currently screens at market cap $1.55B.
Latest reported KROS revenue for 2024-12-31 was $3.5M. Net income was -$187.4M. Revenue was up 2251.0% from 2023-12-31 to 2024-12-31. KROS currently screens at market cap $208.8M.
CLOV currently screens at market cap $1.55B. KROS currently screens at market cap $208.8M.
Not investment advice. Open the CLOV and KROS stock pages for the full models.
Not investment advice.